MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 23 filers reported holding MOLECULIN BIOTECH INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $71,000 | -1.4% | 89,148 | 0.0% | 0.00% | – |
| Q3 2020 | $72,000 | -12.2% | 89,148 | +4.9% | 0.00% | – |
| Q2 2020 | $82,000 | +105.0% | 84,981 | +28.2% | 0.00% | – |
| Q1 2020 | $40,000 | -34.4% | 66,305 | 0.0% | 0.00% | – |
| Q4 2019 | $61,000 | -17.6% | 66,305 | 0.0% | 0.00% | – |
| Q3 2019 | $74,000 | +23.3% | 66,305 | +38.4% | 0.00% | – |
| Q2 2019 | $60,000 | +53.8% | 47,918 | 0.0% | 0.00% | – |
| Q1 2019 | $39,000 | -22.0% | 47,918 | 0.0% | 0.00% | – |
| Q4 2018 | $50,000 | +35.1% | 47,918 | +109.1% | 0.00% | – |
| Q3 2018 | $37,000 | -9.8% | 22,918 | 0.0% | 0.00% | – |
| Q2 2018 | $41,000 | +70.8% | 22,918 | +69.6% | 0.00% | – |
| Q1 2018 | $24,000 | -4.0% | 13,512 | 0.0% | 0.00% | – |
| Q4 2017 | $25,000 | -7.4% | 13,512 | +21.1% | 0.00% | – |
| Q3 2017 | $27,000 | +28.6% | 11,155 | 0.0% | 0.00% | – |
| Q2 2017 | $21,000 | +61.5% | 11,155 | 0.0% | 0.00% | – |
| Q1 2017 | $13,000 | – | 11,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 1,600 | $9,000 | 0.01% |
| Virtu KCG Holdings LLC | 11,614 | $66,000 | 0.00% |
| ING GROEP NV | 20,000 | $122,000 | 0.00% |
| NEXT Financial Group, Inc | 500 | $3,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 917 | $5,000 | 0.00% |
| CITIGROUP INC | 5,000 | $29,000 | 0.00% |
| MORGAN STANLEY | 700 | $4,000 | 0.00% |
| WFG Advisors, LP | 400 | $2,000 | 0.00% |
| UBS Group AG | 2,495 | $14,000 | 0.00% |